Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein-2 Delivered by a Synthetic Polymer and β-Tricalcium Phosphate in a Rabbit Model
Takashi Namikawa(Osaka City University), Kunio Takaoka(Sakurabashi Watanabe Hospital), Hidetomi Terai(Osaka City University), Masatoshi Hoshino(Osaka City University), Eisuke Suzuki(Osaka City University), Shimpei Miyamoto(The University of Tokyo), Hiroaki Nakamura(ConocoPhillips (United States)), Tadashi Ninomiya(Matsumoto Dental University), Naoyuki Takahashi(Matsumoto Dental University), Hiromitsu Toyoda(Osaka City University)
Cited by 55
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
|Journal of Bone and Mineral Research|1996|548